|
1
|
Mariño-Enríquez A and Fletcher CD:
Angiofibroma of soft tissue: Clinicopathologic characterization of
a distinctive benign fibrovascular neoplasm in a series of 37
cases. Am J Surg Pathol. 36:500–508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jin Y, Möller E, Nord KH, Mandahl N, Von
Steyern FV, Domanski HA, Mariño-Enríquez A, Magnusson L, Nilsson J,
Sciot R, et al: Fusion of the AHRR and NCOA2 genes through a
recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma
results in upregulation of aryl hydrocarbon receptor target genes.
Genes Chromosomes Cancer. 51:510–520. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arbajian E, Magnusson L, Mertens F,
Domanski HA, Vult von Steyern F and Nord KH: A novel GTF2I/NCOA2
fusion gene emphasizes the role of NCOA2 in soft tissue
angiofibroma development. Genes Chromosomes Cancer. 52:330–331.
2013. View Article : Google Scholar
|
|
4
|
Schoolmeester JK, Sukov WR, Aubry MC and
Folpe AL: Angiofibroma of soft tissue: Core needle biopsy
diagnosis, with cytogenetic confirmation. Am J Surg Pathol.
36:1421–1423. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sugita S, Aoyama T, Kondo K, Keira Y,
Ogino J, Nakanishi K, Kaya M, Emori M, Tsukahara T, Nakajima H, et
al: Diagnostic utility of NCOA2 fluorescence in situ hybridization
and Stat6 immunohistochemistry staining for soft tissue
angiofibroma and morphologically similar fibrovascular tumors. Hum
Pathol. 45:1588–1596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fukuda Y, Motoi T, Kato I, Ikegami M,
Funata N, Ohtomo R, Horiguchi S, Goto T and Hishima T: Angiofibroma
of soft tissue with fibrohistiocytic features and intratumor
genetic heterogeneity of NCOA2 gene rearrangement revealed by
chromogenic in situ hybridization: A case report. Pathol Int.
64:237–242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Edgar MA, Lauer SR, Bridge JA and Rizzo M:
Soft tissue angiofibroma: Report of 2 cases of a recently described
tumor. Hum Pathol. 44:438–441. 2013. View Article : Google Scholar
|
|
8
|
Schaffer LG, McGowan-Jordan J and Schmid
M: ISCN 2013: An International System for Human Cytogenetic
Nomenclature (2013): Recommendations of the International Standing
Committee on Human Cytogenetic Nomenclature. 1st edition. S. Karger
AG; Basel: 2013
|
|
9
|
Panagopoulos I, Gorunova L, Bjerkehagen B
and Heim S: The ʻgrepʼ command but not FusionMap, FusionFinder or
ChimeraScan captures the CIC-DUX4 fusion gene from whole
transcriptome sequencing data on a small round cell tumor with
t(4;19)(q35;q13). PLoS One. 9:e994392014. View Article : Google Scholar
|
|
10
|
Nicorici D, Satalan M, Edgren H,
Kangaspeska S, Murumagi A, Kallioniemi O, Virtanen S and Kilkku O:
FusionCatcher - a tool for finding somatic fusion genes in
paired-end RNA-sequencing data. bioRxiv 011650. http://dx.doi.org/10.1101/011650.
|
|
11
|
Yamada Y, Yamamoto H, Kohashi K, Ishii T,
Iura K, Maekawa A, Bekki H, Otsuka H, Yamashita K, Tanaka H, et al:
Histological spectrum of angiofibroma of soft tissue: Histological
and genetic analysis of 13 cases. Histopathology. Feb 4–2016.Epub
ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carapeti M, Aguiar RC, Goldman JM and
Cross NC: A novel fusion between MOZ and the nuclear receptor
coactivator TIF2 in acute myeloid leukemia. Blood. 91:3127–3133.
1998.PubMed/NCBI
|
|
13
|
Carapeti M, Aguiar RC, Watmore AE, Goldman
JM and Cross NC: Consistent fusion of MOZ and TIF2 in AML with
inv(8)(p11q13). Cancer Genet Cytogenet. 113:70–72. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Strehl S, Nebral K, König M, Harbott J,
Strobl H, Ratei R, Struski S, Bielorai B, Lessard M, Zimmermann M,
et al: ETV6-NCOA2: A novel fusion gene in acute leukemia associated
with coexpression of T-lymphoid and myeloid markers and frequent
NOTCH1 mutations. Clin Cancer Res. 14:977–983. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sumegi J, Streblow R, Frayer RW, Dal Cin
P, Rosenberg A, Meloni-Ehrig A and Bridge JA: Recurrent t(2;2) and
t(2;8) translocations in rhabdomyosarcoma without the canonical
PAX-FOXO1 fuse PAX3 to members of the nuclear receptor
transcriptional coactivator family. Genes Chromosomes Cancer.
49:224–236. 2010.
|
|
16
|
Panagopoulos I, Thorsen J, Gorunova L,
Micci F and Heim S: Sequential combination of karyotyping and
RNA-sequencing in the search for cancer-specific fusion genes. Int
J Biochem Cell Biol. 53:462–465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Motoi T, Khanin R, Olshen A,
Mertens F, Bridge J, Dal Cin P, Antonescu CR, Singer S, Hameed M,
et al: Identification of a novel, recurrent HEY1-NCOA2 fusion in
mesenchymal chondrosarcoma based on a genome-wide screen of
exon-level expression data. Genes Chromosomes Cancer. 51:127–139.
2012. View Article : Google Scholar
|
|
18
|
Alaggio R, Zhang L, Sung YS, Huang SC,
Chen CL, Bisogno G, Zin A, Agaram NP, LaQuaglia MP, Wexler LH, et
al: A molecular study of pediatric spindle and sclerosing
rhabdomyosarcoma: Identification of novel and recurrent
VGLL2-related fusions in infantile cases. Am J Surg Pathol.
40:224–235. 2016.
|
|
19
|
Mosquera JM, Sboner A, Zhang L,
Kitabayashi N, Chen CL, Sung YS, Wexler LH, LaQuaglia MP, Edelman
M, Sreekantaiah C, et al: Recurrent NCOA2 gene rearrangements in
congenital/infantile spindle cell rhabdomyosarcoma. Genes
Chromosomes Cancer. 52:538–550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deguchi K, Ayton PM, Carapeti M, Kutok JL,
Snyder CS, Williams IR, Cross NC, Glass CK, Cleary ML and Gilliland
DG: MOZ-TIF2-induced acute myeloid leukemia requires the MOZ
nucleosome binding motif and TIF2-mediated recruitment of CBP.
Cancer Cell. 3:259–271. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhuravleva J, Paggetti J, Martin L,
Hammann A, Solary E, Bastie JN and Delva L: MOZ/TIF2-induced acute
myeloid leukaemia in transgenic fish. Br J Haematol. 143:378–382.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaneko Y, Yoshida K, Handa M, Toyoda Y,
Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F and Fujinaga
K: Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12)
chromosome translocation in an undifferentiated sarcoma of infancy.
Genes Chromosomes Cancer. 15:115–121. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Urano F, Umezawa A, Hong W, Kikuchi H and
Hata J: A novel chimera gene between EWS and E1A-F, encoding the
adenovirus E1A enhancer-binding protein, in extraosseous Ewing's
sarcoma. Biochem Biophys Res Commun. 219:608–612. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Braunreiter CL, Hancock JD, Coffin CM,
Boucher KM and Lessnick SL: Expression of EWS-ETS fusions in NIH3T3
cells reveals significant differences to Ewing's sarcoma. Cell
Cycle. 5:2753–2759. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tomlins SA, Mehra R, Rhodes DR, Smith LR,
Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, et al:
TMPRSS2:ETV4 gene fusions define a third molecular subtype of
prostate cancer. Cancer Res. 66:3396–3400. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han B, Mehra R, Dhanasekaran SM, Yu J,
Menon A, Lonigro RJ, Wang X, Gong Y, Wang L, Shankar S, et al: A
fluorescence in situ hybridization screen for E26
transformation-specific aberrations: Identification of DDX5-ETV4
fusion protein in prostate cancer. Cancer Res. 68:7629–7637. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hermans KG, Bressers AA, van der Korput
HA, Dits NF, Jenster G and Trapman J: Two unique novel
prostate-specific and androgen-regulated fusion partners of ETV4 in
prostate cancer. Cancer Res. 68:3094–3098. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Y, Yan X and Zhou T: TBCK influences
cell proliferation, cell size and mTOR signaling pathway. PLoS One.
8:e713492013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiong G, Deng L, Zhu J, Rychahou PG and Xu
R: Prolyl-4-hydroxylase α subunit 2 promotes breast cancer
progression and metastasis by regulating collagen deposition. BMC
Cancer. 14:12014. View Article : Google Scholar
|
|
30
|
Chang KP, Yu JS, Chien KY, Lee CW, Liang
Y, Liao CT, Yen TC, Lee LY, Huang LL, Liu SC, et al: Identification
of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity
squamous cell carcinoma by comparative tissue proteomics of
microdissected specimens using iTRAQ technology. J Proteome Res.
10:4935–4947. 2011. View Article : Google Scholar : PubMed/NCBI
|
